Dean Y. Li serves as Executive at Merck & Co., Inc., where they oversee executive responsibilities. Since joining the company, Dean Y. Li has executed 59 insider transactions totaling $4.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 20, 2021 involved transacting 1,350,000 shares valued at $0.
Dean Y. Li currently holds 92,035.05 shares of Merck & Co., Inc. (MRK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dean Y. Li has been a net seller of MRK stock. They have purchased $0 and sold $4.5M worth of shares.
Dean Y. Li's most recent insider trade was on Apr 20, 2021, when they sold 1,350,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 20, 2021 | RXRX | $0 | Other | 582,501 | $N/A | Discretionary |
| Apr 20, 2021 | RXRX | $0 | Other | 1,350,000 | $N/A | Discretionary |
| Apr 20, 2021 | RXRX | $0 | Other | 1,422,048 | $N/A | Discretionary |
| Apr 20, 2021 | RXRX | $0 | Other | 1,422,048 | $N/A | Discretionary |
| Apr 20, 2021 | RXRX | $0 | Other | 450,000 | $N/A | Discretionary |
| Apr 16, 2021 | RXRX | $0 | Award | 13,889 | $N/A | Discretionary |
| Feb 26, 2021 | MRK | $253.1K | Award | 3,485 | $72.62 | Discretionary |